Position
Fidelity in Avalo Therapeutics, Inc.
Back to the book · All holders of AVTX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $10.2M$14.93 → $18.48
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 220.3K | $4M | — | — | — | 0.0% |
| Q1 2026 | 2.88M | $43M | $14.93 | −$711.6K | $39.7M | 0.0% |
| Q2 2026 | 5.1M | $94.3M | $18.48 | $10.2M | $41M | 0.0% |